Adherent and invasive Escherichia coli (AIEC) associated with Crohn's disease are able to survive and to replicate extensively in active phagolysosomes within macrophages. AIEC-infected macrophages release large amounts of tumour necrosis factor-alpha (TNF-a) and do not undergo cell death. The aim of the present study was to determine what benefit AIEC bacteria could gain from inducing the release of large amounts of TNF-a by infected macrophages and to what extent the neutralization of TNF-a could affect AIEC intramacrophagic replication. Our results showed that the amount of TNF-a released by infected macrophages is correlated with the load of intramacrophagic AIEC bacteria and their intracellular replication. TNF-a secretion was not related to the number of bacteria entering host cells because when the number of bacteria internalized in macrophage was decreased by blocking lipid raft-dependent and clathrin-coated pits-dependent endocytosis, the amount of TNF-a secreted by infected macrophages was not modified. Interestingly, dose-dependent increases in the number of intracellular AIEC LF82 bacteria were observed when infected macrophages were stimulated with exogenous TNF-a, and neutralization of TNF-a secreted by AIEC-infected macrophages using anti-TNF-a antibodies induced a significant decrease in the number of intramacrophagic bacteria. These results indicate that AIEC bacteria use TNF-a as a Trojan horse to ensure their intracellular replication because replication of AIEC bacteria within macrophages induces the release of TNF-a, which in turn increases the intramacrophagic replication of AIEC. Neutralizing TNF-a secreted by infected macrophages may represent an effective strategy to control AIEC intracellular replication.
Crohn's disease (CD) and ulcerative colitis are two major forms of idiopathic inflammatory bowel diseases, with a combined prevalence of about 150-200 cases per 100 000 in the Western countries. They are multifactorial diseases, occurring in individuals with genetic predisposition in whom an environmental and/or infectious trigger causes an abnormal immune response. 1, 2 The theory of dysregulated host responses to intracellular microorganisms is emerging as a contributing factor in CD pathogenesis. The identification of the NOD2 (nucleotide-binding oligomerization domain 2) gene and the autophagy genes, ATG16L1 and IRGM, which are involved in the recognition and the elimination of intracellular bacteria, as susceptibility genes contributing to CD strengthen the hypothesis of the involvement of invasive bacteria in the ileal form of CD. [3] [4] [5] [6] [7] [8] The presence of intramucosal Escherichia coli or mucosaassociated E. coli with invasive properties in CD patients has been reported in independent studies performed in the Europe and the United States.
9-14 CD-associated E. coli are highly adherent and invasive, and accordingly they were termed adherent-invasive E. coli (AIEC). 15 They form a biofilm on the surface of the ileal mucosa owing to abnormal expression of the specific host receptor CEACAM6 recognizing type 1 pili variant expressed by CD-associated E. coli bacteria. 16, 17 Recent data showed that AIEC bacteria are able to target M cells on Peyer's patches through the expression of long polar fimbriae, allowing them to translocate across the intestinal epithelial barrier 18 and that defects in autophagy linked to mutations in ATG16L1, IRGM and NOD2 favour AIEC replication within epithelial cells and dendritic cells. [19] [20] [21] Macrophages serve as the first line of defence by ingesting and destroying invading microorganisms by means of a vast and sophisticated arsenal of microbicidal features. Although most bacteria are successfully internalized and eliminated by macrophages, many pathogenic bacteria have developed survival strategies that interfere with the internalization and/ or phagosomal maturation processes. 22 AIEC bacteria are able to survive and to replicate extensively within macrophages. 23 The bacteria replicate in large vacuoles that have phagolysosome-like properties within macrophages, where they are exposed to low pH and to the degradative activity of cathepsin D. 24 AIEC-infected macrophages release large amounts of tumour necrosis factor-alpha (TNF-a). 23 Pathogen-induced apoptosis of macrophages is a common end for pathogenic strategies, 25 but AIEC-infected macrophages do not undergo cell death. 23 This probably results in the formation of granulomas, as observed with the in vitro model of human granulomas, in which AIEC LF82 induces aggregation of infected macrophages, and sometimes their fusion to form multinucleated giant cells, and subsequent recruitment of lymphocytes. 26 Secretion of TNF-a by infected monocytes/macrophages is a common feature of pathogenic bacteria, but impaired macrophage TNF-a secretion has been reported following infection with some of them such as Brucella spp., meningitidis-associated E. coli K1, and Francisella tularensis. [27] [28] [29] In addition, TNF-a can have opposite effects on intracellular bacteria replication. It allows the multiplication of intramacrophagic Mycobacterium tuberculosis 30 or can provide a suppressive environment for certain pathogenic bacteria such as Legionella pneumophila, Coxiella burnetii and Brucella spp. by inhibiting their intracellular replication. [31] [32] [33] [34] [35] The aim of the present study was to determine (i) what benefit AIEC bacteria could gain from the release of high amounts of TNF-a by infected macrophages and (ii) to what extent the neutralization of TNF-a could affect the intramacrophagic replication of AIEC bacteria.
MATERIALS AND METHODS
Bacterial Strains and Plasmids AIEC strain LF82 was isolated from a chronic ileal lesion of a patient with CD. The LF82 fim mutant harbouring Tn5phoA transposon in fimA does not synthesize type 1 pili. 36 The LF82-DhtrA isogenic mutant is unable to replicate within J774 macrophages. 37 Salmonella enterica serovar Typhimurium strain LT2 was used in this study. 38 Plasmid pFPV25.1, which encodes the green fluorescent protein (GFP), was used to visualize bacteria for confocal microscopy analysis. 39 
Cell Culture
The murine macrophage-like cell line J774 (American Type Culture Collection no. TIB67) was maintained in an atmosphere containing 5% CO 2 at 37 1C in RPMI 1640 medium (Lonza, Saint Beauzire, France) supplemented with 10% (vol/vol) fetal calf serum (FCS; Lonza) and 1% L-Glutamine (Lonza).
Antibodies and Reagents
Goat antibodies against mouse TNF-a for the neutralization of TNF-a bioactivity were purchased from R&D Systems (Lille, France). Mouse IgG 1 isotype control antibodies were obtained from DSHB (Iowa, USA). Goat antibodies against clathrin were obtained from Sigma. Rabbit antiserum against E. coli lipopolysaccharide (LPS) O83 was generously provided by Lothar Beutin (Department of Biological Safety, Robert Koch Institut, Berlin, Germany). FITC-conjugated anti-goat IgG and Cy3-conjugated anti-rabbit IgG (Molecular Probes, Interchim, Montluçon, France) were used as secondary antibodies. FITC-labelled cholera toxin B (CTX B) subunit was obtained from Sigma. Vacuolar pH-neutralizing reagents (chloroquine (CQ) and ammonium chloride (NH 4 Cl)) were obtained from Sigma. Tetramethyl rhodamine isothiocyanate-labelled phalloidin and E. coli LPS O111:B4 were obtained from Sigma. TNF-a and IFN-g were obtained from R&D Systems and ImmunoTools, respectively.
Gentamicin-Killed Bacteria AIEC bacteria were suspended at DO ¼ 0.1 in PBS and were incubated for 30 min with gentamicin at 5 mg/ml before macrophages infection. Killing of bacteria was checked by plating on LB agar.
Macrophage Uptake and Survival Assays J774 macrophages were seeded in 24-well tissue culture plates at a density of 2 Â 10 5 cells/cm 2 . Internalization of bacteria within cells and the ability of bacteria to survive within macrophages were determined by the gentamicin protection assay. 37 When not stated, J774 monolayers were infected at a multiplicity of infection (MOI) of 100 bacteria per macrophage. After 10 min of centrifugation at 1000 g and a 10 min incubation period at 37 1C with 5% CO 2 , fresh cell culture RPMI 1640 medium supplemented with 10% heat-inactivated FCS and containing 20 mg/ml of gentamicin was added for a period of 40 min (1 h post infection) or 24 h (24 h post infection) and the number of intracellular bacteria was determined as previously described. 37 Macrophage Uptake Inhibition Cell monolayers were washed twice with PBS and the medium was replaced with 1 ml of RPMI 1640 without FCS and containing the given drug. Cells were pre-treated with chlorpromazine (CPZ; Sigma) at concentrations of 2.5, 5 and 10 mg/ml, and with methyl-b-cyclodextrin (MbCD; Sigma) at concentrations of 5 and 10 mM for 1 h before infection. Macrophages were infected as described above.
Treatment with Vacuolar pH-Neutralizing Reagents
Macrophages were infected as described above. NH 4 Cl (Sigma) at 30 mM and CQ (Sigma) at 10 mM were used to neutralize the vacuolar pH. The reagents were added to cells at 1 h post infection. Infected and untreated cells were analyzed in parallel.
Supplementation with Exogenous TNF-a and IFN-c Macrophages were infected as described above. TNF-a at 10, 25 and 50 ng/ml was added to cells after infection in the medium containing gentamicin. Macrophages were pre-treated with IFN-g at 100 U/ml for 12 h before AIEC infection, and IFN-g was maintained along experiments. Infected and untreated cells were analyzed in parallel.
TNF-a Neutralization
Macrophages were infected as described above. Anti-TNF-a antibodies and isotype antibodies at 1 mg/ml were added during infection and after infection in the medium containing gentamicin. Infected and untreated cells were analyzed in parallel.
Enzyme-Linked Immunosorbent Assay for TNF-a Quantification
Macrophages seeded in 24-well tissue culture plates at a density of 1 Â 10 5 cells/cm 2 were infected at an MOI of 100 as described above. At 24 h post infection, supernatants were collected, centrifuged and stored at À80 1C. As a positive control of induced TNF-a secretion, cells were stimulated with 1 mg of E. coli O111:B4 LPS (Sigma) per ml. The amount of TNF-a released in the culture supernatant was determined by enzyme-linked immunosorbent assay (ELISA; R&D systems). The optical density was determined at a wavelength of 450 nm, and cytokine concentrations were assessed according to the manufacturer's instructions.
Confocal Microscopy
To detect localization of GM1 gangliosides, macrophage monolayers were incubated for 40 min at room temperature with CTX B at 10 mg/ml and then fixed. When necessary, the actin cytoskeleton was stained for 15 min with TRITClabelled phalloidin at 1 mg/ml (Sigma). To determine the percentage of positive AIEC LF82-containing phagosomes for a specific marker, at least 100 bacteria-containing phagosomes were counted and scored for the presence or absence of the marker protein. Cells were observed with a Zeiss LSM 510 Meta confocal microscope (ICCF, IFR79 Santé Université d'Auvergne, Clermont-Ferrand, France). Each confocal microscopy image is representative of three independent experiments.
Cell Viability
For each drug used in this study, macrophage viability was checked by Trypan blue dye exclusion assays and by measurement of lactate dehydrogenase release. 23 
Statistical Analysis
Student's t test was used for comparison of the two groups of data. All experiments were done at least three times. A P-value of r0.05 was considered statistically significant.
RESULTS

TNF-a Production by AIEC LF82-Infected Macrophages is Related to the Number of Intracellular Bacteria
A phenotypic characteristic of AIEC bacteria is their ability to induce the secretion of TNF-a by infected macrophages. 23 The secretion of TNF-a was analyzed according to the MOI of macrophages with AIEC bacteria. TNF-a quantification at 24 h post infection in the supernatant of AIEC LF82-infected macrophages indicated a MOI-dependent increase ( Figure 1a ) and, as shown in Figures 1b and c, the amount of TNF-a released was related to the number of bacteria entering and replicating within macrophages. When infections were performed with gentamicin-killed bacteria to determine the part of TNF-a secreted by AIEC-infected macrophages related to extracellular pattern recognition receptor (PRR) stimulation by bacteria, we observed that the amount of TNF-a secreted was significantly lower than that observed with macrophages infected with live AIEC bacteria (Figure 1d ). This indicated that TNF-a secretion in response to AIEC infection is dependent on extracellular PRR stimulation but also on intramacrophagic AIEC bacteria stimulation.
AIEC bacteria are able to greatly replicate within macrophages without escaping from the phagosome. 23 An acidic environment is required for the intracellular replication of AIEC bacteria. 24 To determine whether TNF-a production by infected macrophage is related to the ability of AIEC LF82 bacteria to replicate intracellularly, macrophages were treated with NH 4 Cl and CQ, two vacuolar pH-neutralizing agents previously shown to decrease the replication of intracellular AIEC LF82 bacteria (Figure 2a) . Interestingly, the blockade of AIEC bacteria replication by neutralization of the intravacuolar pH decreased TNF-a secretion by macrophages in comparison to that of untreated macrophages (Figure 2b ). We also analyzed the amount of TNF-a released at 24 h post infection by macrophages infected with the LF82-DhtrA isogenic mutant. As previously reported, 37 this mutant is not affected in its ability to enter macrophages (Supplementary Figure S1a) but is unable to replicate intracellularly (Figure 2a and Supplementary Figure  S1b ). In correlation with the absence of intramacrophagic bacteria replication, we observed that the amount of TNF-a released by macrophages infected with this mutant was reduced compared with that of macrophages infected with the wild-type strain LF82 and similar to that observed with LPS stimulated macrophages (Figure 2b ). Of note, we observed that the vacuolar pH-neutralizing agents CQ and NH 4 Cl were very potent inducers of killing of non-replicating AIEC intramacrophagic mutant and suppressors of TNF-a release ( Supplementary Figure S2) . Together, these results indicated that a part of TNF-a secreted by AIEC-infected macrophages is related to the number of intramacrophagic AIEC bacteria.
Inhibition of AIEC LF82 Endocytosis Decreased the Numbers of AIEC LF82 Bacteria Internalized within
Macrophages, but Does Not Interfere with the Secretion of TNF-a Many pathogenic bacteria enter host cells by hijacking lipid raft and clathrin-coated pit endocytic pathways. 40, 41 The entry of AIEC LF82 bacteria involves lipid rafts as we observed that CTX B subunit, a drug that binds the GM1 gangliosides known to be clustered in lipid rafts, was recruited and accumulated around AIEC LF82 entering bacteria (Figure 3a ). This was confirmed by treatment of macrophages with MbCD, a cholesterol-depleting molecule that induced a 1.9-fold decrease in the number of LF82 bacteria internalized in macrophages (Figure 3b ). In addition, AIEC bacteria used clathrin-dependent endocytosis to enter macrophages, as confocal microscopy experiments using an antibody directed against clathrin showed that after 20 min of infection, 37.5 ± 2.8% of AIEC LF82 bacteria colocalized with clathrin (Figure 3d ). Clathrindependent endocytosis of AIEC bacteria was confirmed by pre-treatment of macrophages with increased concentrations of CPZ that induced dose-dependent decreases in the numbers of AIEC LF82 bacteria internalized within macrophages (Figure 3e ). These experiments indicated that both lipid raft-and clathrin-coated pit-mediated endocytosis are involved in the entry of AIEC LF82 within macrophages. However, there was no significant difference between the amounts of TNF-a secreted by AIEC-infected macrophages treated with drugs inhibiting lipid raft-or clathrin-coated pit-mediated endocytosis and by untreated macrophages (Figures 3c and f) . These results indicated that the amount of TNF-a secreted by AIEC-infected macrophages was not related to the number of bacteria entering host cells.
The Amount of TNF-a Released by AIEC LF82-Infected Macrophages is Related to Intracellular Bacteria Replication
The amount of TNF-a secreted following cell infection by the LF82 non-piliated mutant 52D11 was compared with that obtained for LF82-infected macrophages as we observed that this mutant was internalized 2.4-fold less efficiently within macrophages than the wild-type strain LF82 (Figure 4a ) and that the percentages of intracellular bacteria at 24 h post infection relative to 1 h post infection were not significantly different (P40.05) for the wild-type strain LF82 and for the 52D11 mutant (Figures 4b and c) . No significant difference (P40.05) in the level of secreted TNF-a was also observed in the supernatant of 52D11 mutant-and AIEC LF82-infected 
TNF-a favours intracellular AIEC replication
M-A Bringer et al macrophages (Figure 4d ). This suggests that the amount of TNF-a secreted is not related to the number of AIEC bacteria entering host cells but is correlated with AIEC intracellular replication.
TNF-a Enhances the Intramacrophagic Replication of AIEC LF82 Bacteria
We investigated whether TNF-a could favour the intracellular division of AIEC bacteria by measuring the number of intracellular bacteria at 24 h post infection following treatment of the AIEC LF82-infected macrophages with various concentrations of TNF-a. Significant dose-dependent increases in intracellular AIEC LF82 bacteria were observed when infected macrophages were stimulated with exogenous TNF-a during the post-infection period (Figure 5a ). Such increased number of intracellular bacteria within TNF-a-treated macrophages does not result from an enhanced AIEC bacteria internalization within cells (Supplementary Figure S3a) . Of note, when macrophages were treated with vacuolar pH-neutralizing agents such as CQ or NH 4 Cl, the increase in the number of intracellular LF82 bacteria within TNF-a-treated macrophages was no longer observed ( Figure 5d ). For comparison, experiments were also performed with Salmonella enterica serovar Typhimurium, a pathogen known to replicate within macrophages and to induce TNF-a release by infected macrophages. The number of intracellular S. Typhimurium was determined at 1 h and 8 h post infection with untreated cells or macrophages treated with exogenous TNF-a. Interestingly and in contrast to the results observed with AIEC bacteria, macrophage treatment with exogenous TNF-a did not modify the ability of S. Typhimurium to replicate within J774 macrophages (Figure 5b ). TNF-a treatment did not also modify the ability of Salmonella to enter macrophages (Supplementary Figure S3b) . These results suggest that the ability of exogenous TNF-a to enhance intramacrophagic replication is not a common feature of pathogenic bacteria. To define whether the enhanced AIEC intramacrophagic replication was unique to TNF-a stimulation, macrophages were treated with IFN-g. We observed that the pre-treatment of macrophages with IFN-g induced the killing of B50% of intramacrophagic AIEC bacteria (Figure 5a ), indicating that IFN-g, a cytokine known to 
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enhance lysosomal function and bacterial killing, has opposite effect than that of TNF-a on intramacrophagic AIEC behaviour.
To provide further evidence that TNF-a has a positive effect on the intracellular replication of AIEC LF82 bacteria within macrophages, we treated infected cells with anti-TNF-a antibodies. Results showed that neutralization of TNF-a secreted by infected macrophages using anti-TNF-a antibodies induced significant decrease in the number of intramacrophagic bacteria at 24 h post infection (Figure 5c ). As a control, treatment of macrophages with isotype control antibodies did not modify the number of intramacrophagic bacteria at 24 h post infection. The decrease in the numbers of intracellular bacteria observed at 24 h post infection after treatment with anti-TNF-a antibodies was not due to decreased internalization of AIEC bacteria (Supplementary Figure S3c) . This reinforces our results demonstrating that TNF-a released by the infected macrophages favours intracellular replication of AIEC LF82 bacteria.
DISCUSSION
Increased colonization of the ileal mucosa by AIEC is observed in CD patients.
9-14 AIEC bacteria have the ability to survive and replicate within macrophages. 23 They do not escape from the endocytic pathway but undergo normal interaction with host endomembrane organelles. AIEC bacteria replicate within acidic and cathepsin D-positive vacuolar phagolysosomes. 24 We show here that AIECinfected macrophages secrete amounts of TNF-a according to the number of AIEC bacteria in contact with macrophages. Such TNF-a secretion correlated to the number of bacteria in contact with host cells has already been observed in the supernatant of macrophages infected with M. tuberculosis and L. pneumophila. 30, 42 However, secretion of TNF-a by infected monocytes/macrophages is not a common feature of pathogenic bacteria. Indeed, TNF-a production is impaired following macrophage infection by Brucella spp., meningitidis-associated E. coli K1, and F. tularensis.
27-29
In light of the observation that the amount of TNF-a secreted was correlated to the number of bacteria entering and replicating within macrophages two hypotheses emerged: either the amount of TNF-a released is directly related to extracellular PRR stimulation by bacteria in contact with host cells or it is due to the intracellular PRR stimulation by AIEC bacteria surviving and highly replicating within macrophages, or both. Comparison of amounts of TNF-a released by macrophages infected with live or killed bacteria revealed that TNF-a secretion in response to AIEC infection is dependent on extracellular PRR stimulation but also on intramacrophagic AIEC bacteria stimulation. In addition, when the number of AIEC bacteria entering macrophages was decreased by treating cells with endocytosis inhibitors no significant modifications in the level of secreted TNF-a was observed.
To determine whether AIEC replication inside active phagolysosomes was directly responsible for the TNF-a secretion we treated macrophages with the lysosomotropic agents CQ, a drug already used successfully in the treatment of Q fever by restricting intracellular C. burnetii replication within macrophages, 43 and NH 4 Cl, both drugs being able to neutralize intraphagosomal acid pH. These drugs are also highly effective in limiting AIEC intramacrophagic replication, 24 and in the present study we observed a subsequent decreased TNF-a secretion in response to AIEC infection in treated macrophages compared with untreated macrophages. As the decrease in TNF-a secretion could be due to treatments of macrophages with intravacuolar-neutralizing agents or to a decrease in the number of bacteria internalized in macrophages, we performed experiments with macrophages infected with the LF82-DhtrA isogenic mutant, which is not affected in its ability to enter macrophages but does not replicate intracellularly. 37 A similar decreased amount of TNF-a released by macrophages infected with wild-type bacteria or the LF82-DhtrA isogenic mutant was observed. In addition, when macrophages were infected with the nonpiliated 52D11 mutant no changes in the amount of TNF-a released were observed. Of note for this type 1 pili mutant less bacteria are internalized within macrophages but they highly replicated within large vacuoles. Thus, these data indicated that in addition to TNF-a secreted due to stimulation of macrophages by extracellular AIEC bacteria, part of TNF-a secreted is due to intracellular AIEC replication. Such a result has a therapeutic potential as we can speculate that preventing internalization of AIEC bacteria does not appear as a good strategy to reduce TNF-a secretion whereas drugs able to control intramacrophagic bacteria replication could be efficient to limit TNF-a secretion.
TNF-a can have opposite effects on intracellular bacteria replication. For many intracellular pathogens the secretion of TNF-a by immune cells provides a suppressive environment. This has been well documented for L. pneumophila, C. burnetii and Brucella. Treatment of mouse macrophages or human monocytes with TNF-a inhibited the intracellular multiplication of L. pneumophila. 34, 35 It has been reported that C. burnetii replication in human monocytes involves the down-modulation of TNF-a. 33 In addition, TNF-a contributes to host resistance to intracellular Brucella at different stages of infection and exogeneously added TNF-a reduces the ability of Brucella to multiply within human macrophages. 31, 32 In contrast, TNF-a can favour intracellular bacteria replication. Indeed, supplementation of macrophages with exogenous TNF-a has been reported to accelerate the multiplication of intracellular Mycobacterium. 30 We show in the present study that in contrast to what we observed for S. enterica serovar Typhimurium, addition of exogenous TNF-a to AIEC-infected cells increased the number of intracellular bacteria and conversely AIEC-infected cells treated with antibodies that neutralize the bioactivity of TNF-a decreased the number of intracellular bacteria. In the opposite, treatment of macrophages with IFN-g, a cytokine known to render macrophages more resistant to bacterial growth in part by enhancing lysosomal functions, induced AIEC bacteria killing.
The observation that TNF-a favours the intramacrophagic replication of AIEC bacteria suggests that TNF-a may not only harm the mucosa of CD patients but could also directly support the survival and/or replication of AIEC bacteria within macrophages. The mechanism by which TNF-a promotes AIEC intramacrophagic replication is still unclear. TNF-a is known to activate antiapoptotic signals. 44 We can therefore speculate that TNF-a secreted by AIEC-infected macrophages together with AIEC infection by itself could interfere with apoptosis and thus prevent cell death and support the establishment of an intramacrophagic replication niche for AIEC bacteria. TNF-a is also reported to have a role in iron metabolism via the regulation of ferritin expression. 45 Iron is required by bacteria for various metabolic processes that are crucial for microbial replication, including electron transport, glycolysis, DNA synthesis and defence against toxic reactive oxygen intermediates. 46 To acquire iron, bacteria have developed specialized iron-uptake systems. Screening of the AIEC LF82 genome has revealed the presence of various iron-uptake systems. By increasing the availability of iron to AIEC bacteria, TNF-a could facilitate their growth. However, we have previously shown that exogenous iron supplementation of AIEC-infected macrophages does not enhance their intracellular replication. 24 Finally, as AIEC bacteria inhabit in a phagolysosome and as the acid pH of this compartment is required for the intramacrophagic AIEC bacteria replication, 24, 37, 47 the way in which TNF-a favours the survival and/or replication of AIEC bacteria could be related to the ability of TNF-a to enhance phagosome maturation and to induce phagosome acidification. Interestingly, similar results to those we observed with AIEC bacteria were previously reported with M. tuberculosis. In macrophages infected with M. tuberculosis, anti-TNF-a monoclonal antibodies inhibited Mycobacterium-containing phagosome acidification and limited the replication of intramacrophagic mycobacteria. 48 In conclusion, TNF-a is used by AIEC bacteria as a Trojan horse in order to increase their replication within macrophages. An amplification loop exists between TNF-a secretion and AIEC intramacrophagic replication as intracellular replication of AIEC bacteria induces the release of TNF-a, and TNF-a increases the intracellular replication of AIEC. This study gives new insights into an approach to control AIEC replication within macrophages.
